Company Savient Pharmaceuticals Inc Nasdaq
Equities
US80517Q1004
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,373,388 | 71,978,397 ( 98.10 %) | 0 | 98.10 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- SVNTQ Stock
- Stock
- Company Savient Pharmaceuticals Inc